Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
| 2347 | 2 | I 123 MIBG//IODINE 123 METAIODOBENZYLGUANIDINE//METAIODOBENZYLGUANIDINE | 4640 |
| 24677 | 1 | CHICK SYMPATHETIC NEURONS//NORADRENALINE RELEASE//PRESYNAPTIC ALPHA 2 ADRENOCEPTORS | 327 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | CHICK SYMPATHETIC NEURONS | authKW | 385520 | 2% | 67% | 6 |
| 2 | NORADRENALINE RELEASE | authKW | 213851 | 9% | 7% | 31 |
| 3 | PRESYNAPTIC ALPHA 2 ADRENOCEPTORS | authKW | 200788 | 2% | 42% | 5 |
| 4 | MOUSE SYMPATHETIC NEURON CULTURES | authKW | 128507 | 1% | 67% | 2 |
| 5 | PREJUNCTIONAL ALPHA 2 ADRENOCEPTORS | authKW | 108425 | 1% | 38% | 3 |
| 6 | RABBIT HIPPOCAMPUS | authKW | 108425 | 1% | 38% | 3 |
| 7 | 2 CH3 5 HYDROXYTRYPTAMINE | authKW | 96381 | 0% | 100% | 1 |
| 8 | ALPHA 2 ADRENOCEPTOR MECHANISM | authKW | 96381 | 0% | 100% | 1 |
| 9 | ALPHA1 ADRENOCEPTOR CALCIUM CHANNEL BLOCKERS | authKW | 96381 | 0% | 100% | 1 |
| 10 | ALPHA2 ADRENOCEPTOR AUTOINHIBITION | authKW | 96381 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 2190 | 48% | 0% | 156 |
| 2 | Neurosciences | 1440 | 39% | 0% | 128 |
| 3 | Biochemistry & Molecular Biology | 164 | 22% | 0% | 72 |
| 4 | Physiology | 94 | 7% | 0% | 22 |
| 5 | Cell Biology | 5 | 4% | 0% | 14 |
| 6 | Biophysics | 4 | 2% | 0% | 8 |
| 7 | Biology | 3 | 2% | 0% | 5 |
| 8 | Cardiac & Cardiovascular System | 0 | 2% | 0% | 5 |
| 9 | Multidisciplinary Sciences | 0 | 0% | 0% | 1 |
| 10 | Geriatrics & Gerontology | 0 | 0% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | INTERNAL MED 3200 HENRY AVE | 96381 | 0% | 100% | 1 |
| 2 | NEUROBIOL CELLULAR MOLEC | 96381 | 0% | 100% | 1 |
| 3 | STUDY PERIPHERAL NEUROPATHIES NEUROMUSCULAR | 96381 | 0% | 100% | 1 |
| 4 | NEUROBIOLPROGRAMA NEUROIMUNOL | 48190 | 0% | 50% | 1 |
| 5 | SCI S RAFFAELE PHARMACOL | 48190 | 0% | 50% | 1 |
| 6 | PADUALAAN 8 | 8760 | 0% | 9% | 1 |
| 7 | ESTUDOS GERAIS | 4014 | 0% | 4% | 1 |
| 8 | NINEWELLS MED | 925 | 0% | 1% | 1 |
| 9 | BIOMOL MED PHARMACOL | 769 | 0% | 1% | 1 |
| 10 | BIOL CELLULAR ANAT PATOL | 473 | 0% | 0% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 34809 | 14% | 1% | 47 |
| 2 | JOURNAL OF NEUROCHEMISTRY | 4678 | 10% | 0% | 32 |
| 3 | GIORNALE DI GERONTOLOGIA | 3440 | 0% | 4% | 1 |
| 4 | BRITISH JOURNAL OF PHARMACOLOGY | 3346 | 8% | 0% | 25 |
| 5 | JOURNAL OF AUTONOMIC PHARMACOLOGY | 2862 | 2% | 1% | 5 |
| 6 | EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 2244 | 2% | 0% | 5 |
| 7 | EUROPEAN JOURNAL OF PHARMACOLOGY | 1478 | 6% | 0% | 21 |
| 8 | ACTA PHYSIOLOGICA ET PHARMACOLOGICA LATINOAMERICANA | 1435 | 1% | 1% | 2 |
| 9 | ACTA PHARMACOLOGICA SINICA | 1354 | 3% | 0% | 9 |
| 10 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 752 | 4% | 0% | 13 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |